Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingenol Mebutate for Actinic Keratosis in Transplant Recipients
NCT02866695Phase 4Completed
- Sponsor
- University of California, San Francisco
- Start
- Oct 2016
- Primary completion
- Jul 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ingenol mebutate in actinic keratosis (AK), sponsored by University of California, San Francisco. Started Oct 2016; status: completed.
02
Drugs
ingenol mebutate
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT02866695.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866695.